« Back to news listing

TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease

TVA Medical, Inc. (TVA Medical), a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD), announced today that it received $9.5 MM in Series B financing.  S3 Ventures led the round and was joined by TriStar Technology Ventures and existing investor, Santé Ventures.

Read entire article: http://www.heraldonline.com/2013/06/10/4934331/tva-medical-raises-95-million.html#storylink=cpy

« Back to news listing